Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Apply now for the DPUK Autumn Academy: Cohort Data Analysis

DPUK's all-new Autumn Academy is a week-long series of lectures, presentations and group workshops giving researchers in-depth insight into cohort data analysis techniques.

Scientists confirm new way to observe the progress of Alzheimer’s disease in the brain

A new study demonstrates a method of visualising Alzheimer’s progression that could also become a target for new potential treatments.

DPUK and Korea Dementia Research Center to work together for global benefit

Dementias Platform UK (DPUK) is pleased to announce it has signed a memorandum of understanding with the newly launched Korea Dementia Research Center (KDRC).

Report reveals the effects of COVID-19 on dementia research

A new report has found that dementia research has been deprioritised during the COVID-19 pandemic.

Online PET-MR neuroimaging course at Edinburgh University

An online course explores the emerging neuroimaging technique of PET-MR, in which PET and MRI scans are run simultaneously to produce dynamic, high-quality images of the brain.

New Alzheimer's drug aducanumab approved for use in US

DPUK director Professor John Gallacher says the decision to approve the Alzheimer's drug aducanumab for use in the US is 'exciting news' for dementia research.

New study investigating iron and dementia starting in the DPUK Data Portal

Early career researcher Dr Laura Winchester from the University of Oxford will build upon research exploring the link between iron and dementia.

DPUK imaging lead elected to Academy of Medical Sciences

Professor Franklin Aigbirhio, who leads DPUK's Imaging Network, has been elected as a Fellow of the Academy of Medical Sciences.

Imaging harmonisation project resumes after COVID-19 pause

After a pause due to COVID-19 regulations, the harmonisation study to calibrate DPUK's network of eight brain scanners has restarted.

New stem cell platform launched to transform understanding of risk factors for Alzheimer's disease

Dementias Platform UK is to host access to a new cellular model platform that will help researchers explore risk factors that contribute to the development of Alzheimer's disease.

Price of food may influence decision to buy alcohol, new research suggests

People consume less alcohol as the price of food increases, suggesting this may influence the decision to buy it, according to a new study led by Cardiff University and carried out in the DPUK Data Portal.

Researchers improve method of assessing patients with ulcerative colitis

Researchers have developed a more efficient method of assessing symptom change in people with ulcerative colitis – a form of inflammatory bowel disease (IBD).

Aberdeen Children of the 1950s cohort joins DPUK

Dementias Platform UK (DPUK) is pleased to welcome Aberdeen Children of the 1950s (ACONF) as a new cohort in the DPUK Data Portal.

Head injuries may worsen cognitive decline decades later, study suggests

People who experienced head injuries in their 50s or younger score lower than expected on cognitive tests at age 70, according to a study led by UCL researchers and part-funded by DPUK.

DPUK featured in new Alzheimer Europe report on data sharing

Dementias Platform UK (DPUK) has been featured as a case study in the latest report from Alzheimer Europe, a non-profit, non-governmental organisation aiming to make dementia a priority across Europe.

Hearing aids may protect against progression to dementia, study shows

Hearing loss is known to increase a person’s risk of dementia, but new research demonstrates that using hearing aids for hearing difficulties can protect against the condition.

Measuring symptom change in people with dementia: researchers review the methodology

A decline in cognitive ability is one of the hallmarks of dementia. But how do researchers and clinicians accurately measure these changes in symptoms?

Blood test could bring new hope to Alzheimer's clinical trials

Researchers based at UCL have found that blood tests measuring the protein amyloid – a hallmark of Alzheimer's disease – could radically reduce the cost of clinical trials and potentially open the door to treating the disease earlier.

Study shows people with dementia from disadvantaged neighbourhoods wait longer for care home admission

A new study is the first to show a link between socio-economic factors and the time it takes for someone with dementia to be admitted to a care home.

Brain study pinpointing early signs of Alzheimer’s disease seeks participants in Oxford area

Researchers at Oxford University are recruiting volunteers aged 50+ who have either mild cognitive impairment (MCI) or early-stage dementia, as well as neurologically healthy people as an essential comparison to those with memory impairment.

Load More